Oct 2 (Reuters) - Summit Therapeutics on Friday announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo ...
The NHS has shared information about the certain types of coughs that could mean you're suffering from lung cancer. The ...
The WCLC 2026 conference saw updates on new antibody-drug conjugates and treatment protocols for small cell and non-small ...
Toxicities were consistent with deruxtecan ADCs; monitoring for ILD/pneumonitis is essential alongside management of ...
Stocktwits on MSN
Summit teams up with Daiichi Sankyo, AstraZeneca for cancer therapy trial – CEO calls it an 'important expansion'
Datroway cancer therapy has been commercialized by AstraZeneca and Daiichi Sankyo. ・There are currently 16 Phase 3 studies ...
Alex Doan, an MD/PhD candidate and researcher at Fred Hutch Cancer Center and the University of Washington, was recently ...
The NHS has highlighted possible lung cancer warning signs, including certain types of coughs that you should be watching out ...
A single patient with advanced lung cancer has given researchers an intriguing clue about a possible new treatment. After receiving sodium selenite, an experimental compound containing selenium, her ...
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today announced that two ...
The NHS advises contacting your GP if you have a persistent three coughing symptoms that can be signs of lung cancer. It ...
In three deals each worth $2 billion or more, AstraZeneca is investing in Summit Therapeutics with a focus on ivonescimab and ...
Cullinan Therapeutics announced that it has initiated submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for zipalertinib in combination with plat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results